• letter to our shareholders

• company highlights
• consolidated statement of operations

• driving commercial adoption
• expanding reimbursement
• Nikki Woolfolk, Optune user
• Matt Lozano, Senior Device Support Specialist

• advancing our clinical pipeline
• we can leverage physics to fight cancer
• Ori Farber, Senior Medical Manager
• Professor Ignace Vergote, clinical trial investigator

• building long-term shareholder value
• positioned for future growth
• significant unmet medical need
• Tomoe Kamata, Special Project Manager
• Pritesh Shah, Senior Vice President of the Americas

• Novocure leadership

•   downloads